3 research outputs found
Antimicrobial and Anti-inflammatory Cyclic Tetrapeptides from the Co-cultures of Two Marine-Derived Fungi
Violaceotides B–E (1–4),
four new cyclic tetrapeptides, along with seven known compounds, were
identified from the sponge-associated Aspergillus insulicola IMB18-072 co-cultivated with the marine-derived Alternaria
angustiovoidea IMB20-805. Their structures were elucidated
by extensive analysis of spectroscopic data, including HRESIMS, 1D
and 2D NMR, and MS/MS data. The absolute configurations were determined
by the advanced Marfey’s method. Compounds 2, 3, and violaceotide A (5) displayed selective
antimicrobial activities against the aquatic pathogenic bacteria Edwardsiella tarda and E. ictaluri. In
addition, compounds 1–5 showed inhibitory
activities against the LPS-induced expression of the inflammatory
mediator IL-6 in RAW264.7 cells at a concentration of 10 μM
Antimicrobial and Anti-inflammatory Cyclic Tetrapeptides from the Co-cultures of Two Marine-Derived Fungi
Violaceotides B–E (1–4),
four new cyclic tetrapeptides, along with seven known compounds, were
identified from the sponge-associated Aspergillus insulicola IMB18-072 co-cultivated with the marine-derived Alternaria
angustiovoidea IMB20-805. Their structures were elucidated
by extensive analysis of spectroscopic data, including HRESIMS, 1D
and 2D NMR, and MS/MS data. The absolute configurations were determined
by the advanced Marfey’s method. Compounds 2, 3, and violaceotide A (5) displayed selective
antimicrobial activities against the aquatic pathogenic bacteria Edwardsiella tarda and E. ictaluri. In
addition, compounds 1–5 showed inhibitory
activities against the LPS-induced expression of the inflammatory
mediator IL-6 in RAW264.7 cells at a concentration of 10 μM
Identification and Proposed Relative and Absolute Configurations of Niphimycins C–E from the Marine-Derived <i>Streptomyces</i> sp. IMB7-145 by Genomic Analysis
Analysis of the whole genome sequence
of <i>Streptomyces</i> sp. IMB7-145 revealed the presence
of seven type I polyketide synthase biosynthetic gene clusters, one
of which was highly homologous to the biosynthetic gene cluster of
azalomycin F. Detailed bioinformatic analysis of the modular organization
of the PKS gene suggested that this gene is responsible for niphimycin
biosynthesis. Guided by genomic analysis, a large-scale cultivation
ultimately led to the discovery and characterization of four new niphimycin
congeners, namely, niphimycins C–E (<b>1</b>–<b>3</b>) and 17-<i>O</i>-methylniphimycin (<b>4</b>). The configurations of most stereocenters of niphimycins have not
been determined to date. In the present study, the relative configurations
were elucidated by spectroscopic analysis, including <i>J</i>-based analysis and the CNMR database method. Further, the full absolute
configurations of niphimycins were completely proposed for the first
time based on biosynthetic gene cluster analysis of the ketoreductase
and enoylreductase domains for hydroxy- and methyl-bearing stereocenters.
Compounds <b>1</b>, <b>3</b>, <b>4</b>, and niphimycin
Iα (<b>5</b>) showed antimicrobial activity against methicillin-resistant <i>Staphylococcus aureus</i> and vancomycin-resistant enterococci
(MIC: 8–64 μg/mL), as well as cytotoxicity against the
human HeLa cancer cell line (IC<sub>50</sub>: 3.0–9.0 μM).
In addition, compounds <b>1</b> and <b>5</b> displayed
significant activity against several <i>Mycobacterium tuberculosis</i> clinical isolates (MIC: 4–32 μg/mL)